Gene "PLS3"
Found 1 record
Gene information
Gene symbol:
PLS3
See related:
Ensembl: ENSG00000102024, Gene ID: 5358
Additive variants :
Detected
Genetic interaction partners
Confidence      Stringent (ε>0.16 or ε<-0.12)      Intermediate (-0.16≤ε≤-0.08 or 0.08≤ε≤0.16)      Lenient (|ε|<0.08)
Positive interactions
  • ELOVL1 
  • TBC1D22A 
  • VPS26B 
  • SMARCB1 
  • EEF1A2 
  • FA2H 
  • NEK1 
  • ARL13B 
  • HHATL 
  • SHMT2 
  • RANGRF 
  • CYB5B 
  • NF1 
  • EPS15 
  • TCEA3 
  • SGPP2 
  • RAB6B 
  • PRKAG2 
  • LTN1 
  • USP41 
  • VPS35 
  • MRTO4 
  • ENPP2 
  • PIGG 
  • KDM5C 
  • TRMU 
  • GPD2 
  • COQ2 
  • NCBP2 
  • ALG3 
  • CSNK2A2 
  • ARL1 
  • PRMT8 
  • VAC14 
  • RAD54L 
  • PC 
  • RPS29 
  • YME1L1 
  • CCNA2 
  • UBA3 
  • GUF1 
  • SCYL2 
  • PRKG2 
  • MTHFR 
  • SORT1 
  • DUS2 
  • OSBP 
  • RPL27 
  • SLC11A2 
  • ZFP42 
  • LIPT1 
  • HSPA4L 
  • GPCPD1 
  • NFYB 
  • HIBCH 
  • MTHFD2L 
  • ATP23 
  • PUS1 
  • POMT2 
  • MON1B 
  • CERK 
  • SLC3A1 
  • UBE2V2 
  • ROMO1 
  • VPS29 
  • SACM1L 
  • UBE3C 
  • POMT2 
  • CNIH3 
  • NMNAT1 
  • RPS14 
  • PPM1G 
  • GSK3B 
  • PPM1B 
  • DDX21 
  • TTL 
  • MAEA 
  • USP10 
  • PPCDC 
  • TGIF2 
  • IPO9 
  • RHOT2 
  • CACNA1D 
  • RPS6 
  • PPAT 
  • INPP5E 
  • NFU1 
  • RAB7A 
  • ABHD5 
  • SPRYD3 
  • CS 
  • CS 
  • TBL1XR1 
  • DCLRE1B 
  • FAU 
  • PEF1 
  • GPD1L 
  • GLUD2 
  • PFKFB2 
  • CHMP1A 
  • RPUSD2 
  • SHPRH 
  • GOLT1A 
  • CHCHD2 
  • SHMT2 
  • SLC13A4 
  • ALG5 
  • PPP6R3 
  • DNPEP 
  • NAALAD2 
  • HMGB2 
  • FASN 
  • DDX59 
  • KIF26A 
  • GPX7 
  • ERCC6 
  • ZDHHC17 
  • RAB24 
  • HSP90B1 
Negative interactions
  • ZMPSTE24 
  • BMP2K 
  • YEATS4 
  • KIAA1109 
  • PFDN4 
  • MAP3K2 
  • TWF1 
  • CAPZB 
  • ACTR6 
  • LENG8 
  • ATAD2 
  • ATP1A1 
  • CFDP1 
  • BIN3 
  • ADA 
  • RPS25 
  • TKTL2 
  • TUSC3 
  • IDO1 
  • BUD31 
  • RPSA 
  • DNAJA4 
  • PDCD6IP 
  • CORO2B 
  • ARHGAP35 
  • RPL37A 
  • XPNPEP2 
  • RPS8 
  • USP14 
  • GPX7 
  • RPL9 
  • GPT 
  • ELP2 
  • ASH1L 
  • CTU1 
  • STRIP2 
  • ZDHHC6 
  • ERGIC1 
  • H3F3C 
  • XRN1 
  • RPEL1 
  • UBE2D3 
  • RBM34 
  • ELOF1 
  • MRS2 
  • ARHGAP29 
  • TOM1 
  • TRMT10B 
  • LEO1 
  • RPS29 
  • HIST2H4B 
  • SLC38A7 
  • HGS 
  • OLA1 
  • SLC15A4 
  • VRK1 
  • LSM12 
  • PEX12 
  • ATAD1 
  • SIN3A 
  • RPS24 
  • RRAGA 
  • TMED9 
  • RPSA 
  • SC5D 
  • RPL35 
  • RPS6KA1 
  • MOCS3 
  • PM20D1 
  • CNN3 
  • TTF2 
  • BRDT 
  • UBE4B 
  • MRE11 
  • UBA52 
  • KATNA1 
  • PAN3 
  • VPS8 
  • ELP3 
  • RPS3A 
  • PPP2R5C 
  • PPIP5K1 
  • KMO 
  • CDC73 
  • AP2M1 
  • TEAD4 
  • SBF1 
  • OTUD6A 
  • RPS28 
  • MORF4L1 
  • PGLS 
  • RPS4X 
  • NFYC 
  • RPS16 
  • MAN1A2 
  • EVI5 
  • PAQR3 
  • SEL1L 
  • IMMP2L 
  • NSUN2 
  • RACK1 
  • COPS5 
  • MAPK7 
  • MEF2A 
  • ME1 
  • HLTF 
  • GLUD2 
  • WDR45B 
  • GOLPH3L 
  • PLD1 
  • TIPRL 
  • TAPT1 
  • DENR 
  • SLC3A1 
  • ATG9B 
  • PPAN 
  • ALDH16A1 
  • DPYD 
  • PPP2CB 
  • PLAA 
  • GET4 
  • ETFDH 
  • ARHGAP29 
  • PMS1 
  • RHEB 
  • SLC11A2 
  • TESC 
  • TST 
  • AMD1 
  • GSK3B 
Modifier statisitcs
Record:
Disorder:
Vriant:
Reference:
Effect type:
Penetrance(1)  
Modifier effect:
Altered incidence(1)  
Detail:
  • Variant 1:
    Gene:
    Genomic location:
    dbSNP ID:
    Target disease:
    Effect type:
    Penetrance 
    Modifier effect:
    Altered incidence 
    Evidence:
    Pedigree analysis 
    Effect:
    Prevention of disease
    Reference:
    Title:
    Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy.
    Species studied:
    Human
    Abstract:
    Homozygous deletion of the survival motor neuron 1 gene (SMN1) causes spinal muscular atrophy (SMA), the most frequent genetic cause of early childhood lethality. In rare instances, however, individuals are asymptomatic despite carrying the same SMN1 mutations as their affected siblings, thereby suggesting the influence of modifier genes. We discovered that unaffected SMN1-deleted females exhibit significantly higher expression of plastin 3 (PLS3) than their SMA-affected counterparts. We demonstrated that PLS3 is important for axonogenesis through increasing the F-actin level. Overexpression of PLS3 rescued the axon length and outgrowth defects associated with SMN down-regulation in motor neurons of SMA mouse embryos and in zebrafish. Our study suggests that defects in axonogenesis are the major cause of SMA, thereby opening new therapeutic options for SMA and similar neuromuscular diseases.